(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Avogaro A et al. Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes. 1990 Jan-Mar Acta Diabetol Lat pmid:2336923
Al-Awadi F and Shoukry M The lipid lowering effect of an anti-diabetic plant extract. 1988 Jan-Mar Acta Diabetol Lat pmid:3407374
Stangenberg M et al. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy. 1984 Jan-Mar Acta Diabetol Lat pmid:6375226
Micossi P et al. Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation. 1985 Jul-Sep Acta Diabetol Lat pmid:3907236
Gillmer MD et al. Low energy diets in the treatment of gestational diabetes. 1986 Acta Endocrinol Suppl (Copenh) pmid:3532669
Aarsen RS et al. Long-acting somatostatin analogue (Sandostatin) reduces late night insulinopenic ketogenesis in diabetic teenagers. 1987 Acta Endocrinol Suppl (Copenh) pmid:2892337
Styrud J and Eriksson UJ Effects of D-glucose and beta-hydroxybutyric acid on the in vitro development of (pre)chondrocytes from embryos of normal and diabetic rats. 1990 Acta Endocrinol. pmid:2333734
Larsen S et al. The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis. 1991 Acta Endocrinol. pmid:2028708
Home PD et al. Impaired subcutaneous absorption of insulin in 'brittle' diabetics. 1982 Acta Endocrinol. pmid:6756010
De Pergola G et al. D-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomonocytes. 1990 Acta Endocrinol. pmid:2159203